Scholar Rock Holding (SRRK) Assets Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Scholar Rock Holding | 500.61 Mn | 20.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.33% |
| Dec 31, 2025 | -14.88% |
| Sep 30, 2025 | 129.84% |
| Jun 30, 2025 | 49.89% |
| Mar 31, 2025 | 52.48% |
| Dec 31, 2024 | 52.69% |
| Sep 30, 2024 | -28.54% |
| Jun 30, 2024 | -20.37% |
| Mar 31, 2024 | -15.07% |
| Dec 31, 2023 | -13.16% |
| Sep 30, 2023 | -35.77% |
| Jun 30, 2023 | -32.83% |
| Mar 31, 2023 | 18.33% |
| Dec 31, 2022 | 17.65% |
| Sep 30, 2022 | 30.80% |
| Jun 30, 2022 | 27.73% |
| Mar 31, 2022 | -26.24% |
| Dec 31, 2021 | -21.60% |
| Sep 30, 2021 | 82.59% |
| Jun 30, 2021 | 112.36% |
| Mar 31, 2021 | 105.23% |
| Dec 31, 2020 | 97.73% |
| Sep 30, 2020 | -13.32% |
| Jun 30, 2020 | -20.59% |
| Mar 31, 2020 | 2.76% |
| Dec 31, 2019 | 8.30% |
| Sep 30, 2019 | 72.95% |
| Jun 30, 2019 | 65.50% |
| Dec 31, 2018 | 194.20% |